NAMSA Recognized as Leading Medical Device CRO for Third Consecutive Year by Life Science Leader

the world’s only Medical Research Organization (MRO) that accelerates
medical device development through integrated laboratory testing,
clinical research, and regulatory and reimbursement consulting services,
announced today that it has been recognized for excellence in clinical
research and honored for the third consecutive year as a 2019 “CRO
Leadership Award
” winner.

The CRO Leadership Awards are issued by Life
Science Leader
 Magazine and are based on data gathered by Industry
Standard Research
, a full-service biotechnology market research
firm. Recipients of this esteemed award are evaluated against 70+
Clinical Research Organizations (CRO) and selected based on feedback
from Sponsor decision-makers who have utilized clinical research
services within the last 18 months.

NAMSA was ranked as a CRO industry leader in the categories of: 1) Capabilities;
2) Compatibility; and 3) Quality, with top performance
identified in the areas of Data Quality and Access, Meeting
Project Timelines
, Operational Excellence and Responsiveness
over the last three years.

“The CROs receiving an award this year are truly at the top of their
class, and are deserving of this recognition. Being a top performer in
any of these categories shows a level of expertise and commitment to
clinical trials and serving the needs of biotechnology companies and
their patients,” stated Ed Miseta, Executive Editor, Life Science

“This honor is a result of our dedicated focus on providing high quality
services and using client resources judiciously to deliver time and cost
savings throughout the full medical device development continuum. By
combining our scientific knowledge with NAMSA’s MRO®
Approach, clients achieve clinical endpoints more quickly and are
empowered to make effective decisions that accelerate the global
delivery of life-changing medical technologies,” commented NAMSA
President & CEO, John Gorski.

For over 50
, NAMSA has partnered with thousands of global customers to
provide the most critical research services required to accelerate
time-to-market and reduce costs for medical device innovation and
research. Consistently recognized as an industry leader, with an
established track record of providing clients development savings of up
to 23
months and $17M in costs
, NAMSA is dedicated to partnering with
global manufacturers to bring novel medical technology to the
marketplace in the most efficient manner possible.

NAMSA operates 13
throughout North America, Europe and Asia, and employs over
1,000 highly-experienced laboratory testing, clinical research and
regulatory and reimbursement consulting Associates.


a Medical Research Organization (MRO), accelerating medical device
product development through integrated laboratory testing, clinical
research, and reimbursement and regulatory consulting services. Driven
by our regulatory expertise, NAMSA’s MRO® Approach plays an
important role in translational research, applying a unique combination
of disciplines—consulting, regulatory, reimbursement, preclinical,
toxicology, microbiology, chemistry, clinical and quality—to move
clients’ products through the development process, and continue to
provide support through commercialization to post-market requirements
anywhere in the world.

Follow us on Twitter,
LinkedIn or Facebook for
regular updates.


Leah Davidson, MA, MBA
Manager, Marketing Communications
[email protected]

error: Content is protected !!